MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹540 Cr | ₹453 Cr | ₹417 Cr | ₹395 Cr | ₹272 Cr |
What is the latest Sundry Debtors ratio of MARKSANS PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹540 Cr |
| Mar2024 | ₹453 Cr |
| Mar2023 | ₹417 Cr |
| Mar2022 | ₹395 Cr |
| Mar2021 | ₹272 Cr |
How is Sundry Debtors of MARKSANS PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹540 Cr | 19.17 | |
| Mar2024 | ₹453 Cr | 8.72 | |
| Mar2023 | ₹417 Cr | 5.59 | |
| Mar2022 | ₹395 Cr | 45.17 | |
| Mar2021 | ₹272 Cr | - | |
Compare Sundry Debtors of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹9,410.7 Cr | 2.2% | 16.1% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 2.2% |
16.1% |
-9.3% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses